The Psychology of 180 Life Sciences Corp Inc. (ATNF) Price Performance: Understanding Market Sentiment

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant gain of 73.41% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 117.39%. Over the past 30 days, the price of ATNF has fallen by 239.02%. And in the last five days, it has fallen by -15.25%.

180 Life Sciences Corp had a pretty favorable run when it comes to the market performance.

52-week price history of ATNF Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. 180 Life Sciences Corp’s current trading price is -83.10% away from its 52-week high, while its distance from the 52-week low is 356.07%. The stock’s price range for this period has been between $0.66 and $17.75. The Healthcare sector company’s shares saw a trading volume of about 7.27 million for the day, which was higher than the average daily volume of 2.3 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

180 Life Sciences Corp (ATNF) has experienced a quarterly rise of 179.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 462.10M and boasts a workforce of 3 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.30, with a change in price of +1.93. Similarly, 180 Life Sciences Corp recorded 1,594,872 in trading volume during the last 100 days, posting a change of +180.37%.

ATNF’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ATNF stands at 0.26. Similarly, the long-term debt-to-equity ratio is also 0.00.

ATNF Stock Stochastic Average

As of today, the raw stochastic average of 180 Life Sciences Corp over the last 50 days is at 56.79%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 55.01%. Further, the company’s Stochastic %K and %D values for the last 20 days were 63.79% and 65.37%, respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.